ANDERA PARTNERS
Follow13F filer, CIK 1757283, PARIS, France
ANDERA PARTNERS reported $176,607,205 across 5 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001757283-26-000007
- Period
- 2025-12-31
- Reported value
- $177M
- Holdings
- 5
- Top 10 weight
- 100%
- New
- Sold out
Holdings, Q4 2025
Share positions as resolved from 13F-HR 0001757283-26-000007, largest first. % of portfolio is the value over $176,607,205, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| KMTSKESTRA MED TECHNOLOGIES LTD | 2,540,106 | $67.4M | 38.14% | Timeline | |||
| MLYSMINERALYS THERAPEUTICS INC | 1,591,917 | $57.8M | 32.71% | Timeline | |||
| EVMNEVOMMUNE INC | 1,897,362 | $32.5M | 18.39% | Timeline | |||
| ABVXABIVAX SA | 78,125 | $10.5M | 5.97% | Timeline | |||
| IVAINVENTIVA SA | 1,818,181 | $8.45M | 4.79% | Timeline |
How Q4 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001757283-26-000007 | base | 2026-02-17 | acceptance time not in the bulk data set |